Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
April 24th, 2024 |
Building Capacity to Increase Commercial Tobacco Cessation |
Centers for Disease Control NCCDPHP |
March 5th, 2026 |
Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2025 |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) |
National Institutes of Health |
October 26th, 2023 |
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) |
National Institutes of Health |
January 4th, 2024 |
Fiscal Year (FY) 2024 AmeriCorps State and National Competitive Grants |
AmeriCorps |
October 31st, 2023 |
USAID Improved Maternal, Newborn, Child Health, Immunization and Nutrition Activity |
Mozambique USAID Maputo |
September 7th, 2025 |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) |
National Institutes of Health |
October 26th, 2023 |
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
December 4th, 2026 |
Planning for Product Development Strategy (R34 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2027 |
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) |
National Institutes of Health |
November 29th, 2023 |
Understanding and Mitigating Health Disparities experienced by People with Disabilities caused by Ableism (R01 Clinical Trial Optional) |
National Institutes of Health |
September 12th, 2023 |
r USAID's Resilient Health Systems for Healthy, Resilient Communities in DRC |
Democratic Republic of the Congo USAID Kinshasa |
November 3rd, 2023 |
Neural and Non-Neural Mechanisms Underlying Gait as a Preclinical Marker for Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional) |
National Institutes of Health |
May 5th, 2026 |
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 2nd, 2024 |
Community-Engaged Health Equity Research in Neuroscience Initiative (R34 CT Not Allowed) |
National Institutes of Health |
February 6th, 2025 |
HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2026 |
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) |
National Institutes of Health |
February 2nd, 2024 |
Community-Engaged Health Equity Research in Neuroscience Initiative (R01 CT Not Allowed) |
National Institutes of Health |
November 3rd, 2025 |
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) |
National Institutes of Health |
November 3rd, 2025 |
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) |
National Institutes of Health |
|
September 7th, 2026 |
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
November 3rd, 2023 |
Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R21 Clinical Trial Not Allowed) |
National Institutes of Health |
November 3rd, 2023 |
Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 6th, 2024 |
Supporting Young Breast Cancer Survivors, Metastatic Breast Cancer Patients, and their Families |
Centers for Disease Control NCCDPHP |
September 7th, 2026 |
Alcohol Health Services Research (R34 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2026 |
Alcohol Health Services Research (R01 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2026 |
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) |
National Institutes of Health |
September 7th, 2026 |
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) |
National Institutes of Health |
November 3rd, 2023 |
Elucidating Variability of Physiologic and Functional Responses to Exercise Training in Older Adults (R01 Clinical Trial Required) |
National Institutes of Health |
November 5th, 2026 |
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2027 |
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
National Institutes of Health |
July 10th, 2024 |
Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required) |
National Institutes of Health |
May 10th, 2024 |
Expanding the National Approach to Chronic Disease Education and Awareness |
Centers for Disease Control NCCDPHP |
April 15th, 2024 |
Implementing Evidence-Based Health Promotion Programs for Attention-Deficit Hyperactivity Disorder (ADHD) or Tourette Syndrome (TS) |
Centers for Disease Control NCBDDD |
April 8th, 2024 |
NCHHSTP Epidemiologic and Economic Modeling for HIV, Viral Hepatitis, STD, and TB |
Centers for Disease Control NCHHSTP |
March 4th, 2024 |
Strengthening immunization program implementation in sub-national consequential geographies |
Centers for Disease Control CGH |
November 17th, 2023 |
Validating digital health technologies for monitoring biomarkers in ADRD clinical trials (R61/R33 - Clinical Trials Optional) |
National Institutes of Health |
December 6th, 2023 |
Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required) |
National Institutes of Health |
April 8th, 2024 |
Community Programs for Outreach and Intervention with Youth and Young Adults at Clinical High Risk for Psychosis |
Substance Abuse and Mental Health Services Adminis |
April 26th, 2024 |
Assisted Outpatient Treatment Program for Individuals with Serious Mental Illness |
Substance Abuse and Mental Health Services Adminis |